Chargement en cours...
4CPS-135 Effectiveness and cost of eculizumab on patients with atypical (shua), urenic and haemolitic syndrome, with enlargement of the frequency of administration
BACKGROUND: Atypical haemolytic uraemic syndrome (aHUS) is a thrombotic microangiopathy that primarily affects the kidney. PURPOSE: To compare the effectiveness and cost of eculizumab (monoclonal antibody indicated for the treatment of aHUS) on a patient on whom it is administered more frequently as...
Enregistré dans:
| Publié dans: | Eur J Hosp Pharm |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Group
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535341/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.226 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|